TSX:MHCD Holdings Information

TSX:MHCD is an equity ETF with a total of 46 individual holdings. The top holdings are Eli Lilly and Company stock at 7.26%, Johnson & Johnson at 6.52%, AbbVie at 5.31%, Merck & Co. at 4.71%, and AstraZeneca at 4.03%.

Total Holdings

Top 10 Percentage

42.83%

Asset Class

Equity

ETF Category

Health Care

Assets

160.50M

PE Ratio

24.34

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	7.26%	6,600
2	JNJ	Johnson & Johnson	6.52%	28,000
3	ABBV	AbbVie Inc.	5.31%	23,000
4	MRK	Merck & Co., Inc.	4.71%	40,000
5	LON: AZN	AstraZeneca PLC	4.03%	23,500
6	TMO	Thermo Fisher Scientific Inc.	3.81%	8,300
7	SYK	Stryker Corporation	3.03%	10,500
8	DHR	Danaher Corporation	2.76%	15,800
9	SWX: NOVN	Novartis AG	2.73%	19,000
10	UNH	UnitedHealth Group Incorporated	2.67%	7,000
11	TSX: EXE	Extendicare Inc.	2.61%	115,000
12	ISRG	Intuitive Surgical, Inc.	2.59%	7,100
13	TSX: CSH.UN	Chartwell Retirement Residences	2.53%	175,000
14	ABT	Abbott Laboratories	2.41%	29,000
15	MDT	Medtronic plc	2.37%	33,000
16	VRTX	Vertex Pharmaceuticals Incorporated	2.14%	4,700
17	SWX: ROP	Roche Holding AG	2.12%	5,600
18	BMY	Bristol-Myers Squibb Company	2.06%	39,000
19	NTRA	Natera, Inc.	1.99%	8,000
20	MCK	McKesson Corporation	1.94%	2,800
21	HUM	Humana Inc.	1.93%	5,300
22	TSX: APTX	Apotex Health Corp.	1.88%	90,000
23	PFE	Pfizer Inc.	1.79%	81,000
24	AMGN	Amgen Inc.	1.76%	5,300
25	ZBIO	Zenas BioPharma, Inc.	1.74%	75,000

Showing 25 of 46 holdings

Subscribe to see the full list

Activate Now

As of Jun 30, 2026